Trials / Completed
CompletedNCT04738019
A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,022 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This is an observational study to evaluate the incidence of delayed-onset nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 injected into the facial skin layer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Medical examination or treatment. | Medical examination or treatment when delayed on-set nodule or other side effects occur due to Y-Solution filler injection. |
Timeline
- Start date
- 2020-06-18
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
- First posted
- 2021-02-04
- Last updated
- 2023-01-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04738019. Inclusion in this directory is not an endorsement.